These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 33483855)

  • 1. The effects of saxagliptin on cardiac structure and function using cardiac MRI (SCARF).
    Sandhu P; Ong JP; Garg V; Altaha M; Bello O; Singal SR; Verma S; Yan AT; Connelly KA
    Acta Diabetol; 2021 May; 58(5):633-641. PubMed ID: 33483855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between saxagliptin use and left ventricular diastolic function assessed by cardiac MRI.
    Wong KCK; Ismail HS; Connelly KA; Verma S; Ng MY; Deva DP; Yan AT; Jimenez-Juan L
    Acta Diabetol; 2024 Jan; 61(1):91-97. PubMed ID: 37691025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sodium-glucose cotransporter 2 inhibitors on cardiac structure and function in type 2 diabetes mellitus patients with or without chronic heart failure: a meta-analysis.
    Yu YW; Zhao XM; Wang YH; Zhou Q; Huang Y; Zhai M; Zhang J
    Cardiovasc Diabetol; 2021 Jan; 20(1):25. PubMed ID: 33494751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine.
    Hiemstra JA; Lee DI; Chakir K; Gutiérrez-Aguilar M; Marshall KD; Zgoda PJ; Cruz Rivera N; Dozier DG; Ferguson BS; Heublein DM; Burnett JC; Scherf C; Ivey JR; Minervini G; McDonald KS; Baines CP; Krenz M; Domeier TL; Emter CA
    J Am Heart Assoc; 2016 Apr; 5(4):e003277. PubMed ID: 27098966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Magnetic Resonance Left Ventricular Filling Pressure Is Associated with NT-proBNP in Patients with New Onset Heart Failure.
    Assadi H; Matthews G; Chambers B; Grafton-Clarke C; Shabi M; Plein S; Swoboda PP; Garg P
    Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003973
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of glucagon-like peptide-1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: An updated systematic review and meta-analysis.
    Zhang Y; Yang D; Jia Q; Yan J; An F
    Diabetes Obes Metab; 2024 Jun; 26(6):2401-2411. PubMed ID: 38528818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced thoracic skeletal muscle size is associated with adverse outcomes in diabetes patients with heart failure and reduced ejection fraction: quantitative analysis of sarcopenia by using cardiac MRI.
    Shi K; Zhang G; Fu H; Li XM; Yu SQ; Shi R; Yan WF; Qian WL; Xu HY; Li Y; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2024 Jan; 23(1):28. PubMed ID: 38218882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in Cardiac Magnetic Resonance Feature Tracking for Evaluating Myocardial Strain in Type-2 Diabetes Mellitus.
    Shen LT; Shi R; Yang ZG; Gao Y; Jiang YN; Fang H; Min CY; Li Y
    Curr Diabetes Rev; 2024; 20(8):98-109. PubMed ID: 38310480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular magnetic resonance assessment of acute cardiovascular effects of voluntary apnoea in elite divers.
    Eichhorn L; Doerner J; Luetkens JA; Lunkenheimer JM; Dolscheid-Pommerich RC; Erdfelder F; Fimmers R; Nadal J; Stoffel-Wagner B; Schild HH; Hoeft A; Zur B; Naehle CP
    J Cardiovasc Magn Reson; 2018 Jun; 20(1):40. PubMed ID: 29909774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Stroke Volume between Left and Right Ventricles as a Predictor of Clinical Outcomes: The MESA Study.
    Abdollahi A; Kato Y; Bakhshi H; Varadarajan V; Chehab O; Zeitoun R; Ostovaneh MR; Wu CO; Bertoni AG; Shah SJ; Ambale-Venkatesh B; Bluemke DA; Lima JAC
    Radiology; 2024 Jul; 312(1):e232973. PubMed ID: 39041933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of menopausal hormone therapy (MHT) on cardiac structure and function: Insights from the UK Biobank imaging enhancement study.
    Sanghvi MM; Aung N; Cooper JA; Paiva JM; Lee AM; Zemrak F; Fung K; Thomson RJ; Lukaschuk E; Carapella V; Kim YJ; Harvey NC; Piechnik SK; Neubauer S; Petersen SE
    PLoS One; 2018; 13(3):e0194015. PubMed ID: 29518141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early reduction in cardiorespiratory fitness and diastolic reserve following radiation therapy for lung cancer.
    Thomas G; Weiss E; Del Buono MG; Moroni F; West J; Myers R; Kontos E; Golino M; Abbate A; Canada JM
    Cardiooncology; 2024 Mar; 10(1):15. PubMed ID: 38468295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement substance P reduces cardiac fibrosis in monkeys with type 2 diabetes.
    Meléndez GC; Kavanagh K; Gharraee N; Lacy JL; Goslen KH; Block M; Whitfield J; Widiapradja A; Levick SP
    Biomed Pharmacother; 2023 Apr; 160():114365. PubMed ID: 36758315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of systemic inflammation activity, myocardial structure and functional features, their relationship in patients with multiple myeloma, receiving bortezomib therapy].
    Fomina EV; Kardanova SA; Bochkarnikova OV; Murtuzaliev SM; Appolonova SA; Markin PA; Privalova EV; Ilgisonis IS; Belenkov YN
    Kardiologiia; 2023 Nov; 63(10):29-38. PubMed ID: 37970853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron Deficiency Anemia-Induced Cardiomyopathy With Congestive Heart Failure: Reversible Cardiac Dysfunction Assessed by Multi-Imaging Modalities.
    Miura S; Naya M; Yamashita T
    JACC Case Rep; 2020 Sep; 2(11):1806-1811. PubMed ID: 34317060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationship between micronutrients and cardiovascular structure and function in type 2 diabetes.
    Walters GWM; Redman E; Gulsin GS; Henson J; Argyridou S; Yates T; Davies MJ; Parke K; McCann GP; Brady EM
    J Nutr Sci; 2021; 10():e88. PubMed ID: 34733500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Ventricular Stroke Volumes at Cardiac MRI: A Prompt to Search for Volume Overload.
    Almeida AG
    Radiology; 2024 Jul; 312(1):e241350. PubMed ID: 39041934
    [No Abstract]   [Full Text] [Related]  

  • 18. Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists: An Analysis of DAPA-HF.
    Shen L; Kristensen SL; Bengtsson O; Böhm M; de Boer RA; Docherty KF; Inzucchi SE; Katova T; Køber L; Kosiborod MN; Langkilde AM; Lindholm D; Martinez MFA; O'Meara E; Nicolau JC; Petrie MC; Ponikowski P; Sabatine MS; Schou M; Sjöstrand M; Solomon SD; Jhund PS; McMurray JJV
    JACC Heart Fail; 2021 Apr; 9(4):254-264. PubMed ID: 33549554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Canagliflozin in Patients with Type 2 Diabetes after Hospitalization for Acute Heart Failure: A Cohort Study.
    Martín E; López-Aguilera J; González-Manzanares R; Anguita M; Gutiérrez G; Luque A; Paredes N; Oneto J; Perea J; Castillo JC
    J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33535424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapagliflozin in a Real-World Chronic Heart Failure Population: How Many Are Actually Eligible?
    Maltês S; Cunha GJL; Rocha BML; Presume J; Guerreiro R; Henriques C; Rodrigues C; Araújo I; Fonseca C
    Cardiology; 2021; 146(2):201-206. PubMed ID: 33524984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.